These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31738149)

  • 21. [Design, synthesis and activity of a new type of influenza virus N1 neuraminidase inhibitors].
    Yang F; Jin L; Huang NY; Chen F; Luo HJ; Chen JF
    Yao Xue Xue Bao; 2011 Nov; 46(11):1344-8. PubMed ID: 22260026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor.
    Rohini K; Shanthi V
    Cell Biochem Biophys; 2018 Sep; 76(3):357-376. PubMed ID: 29687225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico study of carvone derivatives as potential neuraminidase inhibitors.
    Jusoh N; Zainal H; Abdul Hamid AA; Bunnori NM; Abd Halim KB; Abd Hamid S
    J Mol Model; 2018 Mar; 24(4):93. PubMed ID: 29546582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
    Yu ZJ; Liu S; Zhou S; Li H; Yang F; Yang LL; Wu Y; Guo L; Li GB
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1037-1042. PubMed ID: 29477271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
    Fu SK; Cheng LP
    Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
    Tsukamoto Y; Ikeda S; Uwai K; Taguchi R; Chayama K; Sakaguchi T; Narita R; Yao WL; Takeuchi F; Otakaki Y; Watashi K; Wakita T; Kato H; Fujita T
    PLoS One; 2018; 13(5):e0197664. PubMed ID: 29782545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Biological Evaluation of
    Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
    Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
    Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
    Rakers C; Schwerdtfeger SM; Mortier J; Duwe S; Wolff T; Wolber G; Melzig MF
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4312-7. PubMed ID: 25096296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
    Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
    Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
    Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors.
    Wang PC; Fang JM; Tsai KC; Wang SY; Huang WI; Tseng YC; Cheng YS; Cheng TJ; Wong CH
    J Med Chem; 2016 Jun; 59(11):5297-310. PubMed ID: 27167096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ; Hall RJ
    J Mol Recognit; 2015 Sep; 28(9):521-7. PubMed ID: 25727669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.
    Yen HL; Hoffmann E; Taylor G; Scholtissek C; Monto AS; Webster RG; Govorkova EA
    J Virol; 2006 Sep; 80(17):8787-95. PubMed ID: 16912325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key amino acid residues of neuraminidase involved in influenza A virus entry.
    Chen F; Liu T; Xu J; Huang Y; Liu S; Yang J
    Pathog Dis; 2019 Aug; 77(6):. PubMed ID: 31702775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
    Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
    Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.